Assessing the Impact of Female Genital Mutilation/Cutting on Genital Inflammation and Microbiota Among Kenyan Female Sex Workers
American Journal of Reproductive Immunology · 2026-05 · 95 (5)
DOI: 10.1111/aji.70250 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 04.05.2026. Verfasst von James Pollock und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Sex Workers, Microbiota, Circumcision, Female, HIV Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council (MRC) and the UK Department of International Development (DFID), EDCTP2 supported by the European Union, Canadian Institute of Health Research (CIHR).
Abstract (Originalsprache)
Problem Female genital mutilation/cutting (FGM/C) is harmful to physical, mental, and reproductive health, though the effect of this practice on a woman's HIV susceptibility is poorly understood. Despite the known associations of FGM/C with short‐term vaginal epithelial damage, neither genital inflammation nor the genital microbiome have been explored in women who have undergone FGM/C. In this study we compare the genital immune milieu and microbiome among female sex workers (FSWs) by FGM/C status, hypothesizing that these biological factors are dysregulated in women who have undergone FGM/C, heightening their risk of HIV acquisition. Method of Study 1003 FSWs in Nairobi, Kenya, were enrolled in the Maisha Fiti study and visited a study clinic up to three times from June 2019 to March 2021. Participants self‐reported any previous exposure to FGM/C as well as other relevant sociodemographic factors. Levels of proinflammatory cytokines and soluble E‐cadherin (sE‐cad), a biomarker of epithelial barrier disruption, were measured by multiplex immunoassay using self‐collected cervicovaginal secretion samples provided by HIV‐uninfected participants. Genital inflammation was defined using a composite score of inflammatory cytokines previously associated with HIV acquisition. The presence of inflammation was compared longitudinally between groups using mixed models to control for potential confounders including age, bacterial vaginosis (BV) status as defined by Nugent score, and others. Vaginal bacterial abundance, Shannon diversity, and total levels of key vaginal bacteria were measured by qPCR and compared by FGM/C status in an exploratory analysis.
Results
44 of 1003 (4%) participants had undergone Type I or II FGM/C. These participants were older ( p < 0.001) and more likely to test positive for herpes simplex virus‐2 (HSV‐2; p = 0.04), and less likely to have completed primary education ( p = 0.03). Among HIV‐uninfected participants, there was no evidence that genital inflammation was associated with FGM/C status after controlling for potential confounders (aOR = 0.70; 95% CI: 0.31–1.59; p = 0.40). There was no evidence of a difference in BV prevalence ( p > 0.99), total bacterial abundance ( p = 0.96), or Shannon diversity ( p = 0.15) by FGM/C status.
Conclusions
Type I or II FGM/C was not associated with genital inflammation or microbial dysregulation in the long‐term among HIV‐negative FSWs in this cohort. This may be due to the duration elapsed since FGM/C occurred or the lowered mucosal immune activation previously observed in FSWs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, University of Toronto, Toronto, Canada.
- Department of Medicine, University of Toronto, Toronto, Canada.
- Partners For Health and Development in Africa (PHDA), UNITID, College of Health Sciences, Nairobi, Kenya.
- MRC International Statistics and Epidemiology Group, Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
- Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK.
ORCID-Profile: James Pollock, Rachel Liu, Janet Seeley, Rupert Kaul
Förderung
- Medical Research Council (MRC) and the UK Department of International Development (DFID)
- EDCTP2 supported by the European Union
- Canadian Institute of Health Research (CIHR)
Zitieren
APA
Pollock, J., Liu, R., Rwenji, E., Orobi, E., Udayakumar, S., Huibner, S., Kung'u, M., Kabuti, R., Babu, H., Maisha Fiti Study Champions, Irungu, E., Ngurukiri, P., Muthoga, P., Adhiambo, W., Weiss, H. A., Seeley, J., Abramsky, T., Kimani, J., Beattie, T. S., & Kaul, R. (2026). Assessing the Impact of Female Genital Mutilation/Cutting on Genital Inflammation and Microbiota Among Kenyan Female Sex Workers. American Journal of Reproductive Immunology, 95(5). https://doi.org/10.1111/aji.70250
Vancouver
Pollock J, Liu R, Rwenji E, Orobi E, Udayakumar S, Huibner S, et al. Assessing the Impact of Female Genital Mutilation/Cutting on Genital Inflammation and Microbiota Among Kenyan Female Sex Workers. American Journal of Reproductive Immunology. 2026;95(5). doi:10.1111/aji.70250
BibTeX
@article{Pollock2026,
author = {Pollock, James and Liu, Rachel and Rwenji, Elizabeth and Orobi, Evelyne and Udayakumar, Suji and Huibner, Sanja and Kung'u, Mary and Kabuti, Rhoda and Babu, Hellen and Maisha Fiti Study Champions, Maisha Fiti Study Champions and Irungu, Erastus and Ngurukiri, Pauline and Muthoga, Peter and Adhiambo, Wendy and Weiss, Helen A and Seeley, Janet and Abramsky, Tanya and Kimani, Joshua and Beattie, Tara S and Kaul, Rupert},
title = {Assessing the Impact of Female Genital Mutilation/Cutting on Genital Inflammation and Microbiota Among Kenyan Female Sex Workers},
journal = {American Journal of Reproductive Immunology},
year = {2026},
volume = {95},
number = {5},
doi = {10.1111/aji.70250}
}
EUVIMED